Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
Open-label Pharmacokinetic Trial of Aldesleukin (Rh-Interleukin-2 [IL-2]) Administered Intravenously to Subjects With Metastatic Renal Cell Carcinoma and Metastatic Melanoma With Immunologic Correlative Studies
This study will evaluate the pharmacokinetics of aldesleukin in patients with metastatic
renal cell cancer and metastatic melanoma
We found this trial at
4
sites
James Graham Brown Cancer Center No one should feel compelled to leave Kentucky to seek...
Click here to add this to my saved trials
13001 E. 17th Pl.
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
University of Colorado Cancer Center - Anschutz Cancer Pavilion The University of Colorado Denver |...
Click here to add this to my saved trials
Darien Pediatric Associates Our office is pleased and privileged to care for your children and...
Click here to add this to my saved trials
Click here to add this to my saved trials